Best Practices for Molecular Point-of-Care Testing

This guide presents seven best practices for molecular point-of-care testing (POCT), particularly in the context of the increased demand for testing due to the COVID-19 pandemic. It emphasizes the importance of adhering to the Clinical Laboratory Improvement Amendments of 1988 (CLIA) criteria for waived tests, which are designed to be simple and carry minimal risk of incorrect results. The document outlines essential practices such as providing adequate training for testing personnel, strictly following the Manufacturer’s Instructions for Use (IFU), and conducting regular quality control checks to ensure reliable test outcomes. Additionally, it discusses the significance of proper sample collection, equipment maintenance, contamination control, and utilizing data analysis for accurate reporting. By implementing these best practices, healthcare facilities can enhance the accuracy and reliability of molecular POCT, ultimately improving patient care and trust in testing processes.